Brief: Pliant Therapeutics Q4 Net Income USD -23.577 Million
11/03/2026 20:05
Mar 11 (Reuters) - Pliant Therapeutics Q4 operating income USD -23.577 million. Q4 operating expenses USD -23.577 million
Recent news on Pliant Therapeutics
See all newsPliant Therapeutics Q1 net loss narrows on lower expenses
Brief: Pliant Therapeutics Says Pln-101095 Generally Well Tolerated; Most Common Trae Was Rash, One Grade 3 Trae Observed
Brief: Pliant Therapeutics Announces Upcoming Presentation Of Phase 1 Clinical Trial Of PLN-101095 In Patients With Solid Tumors At The 2026 Aacr Annual Meeting
Pliant Therapeutics Q4 net loss narrows on lower costs
Brief: Pliant Therapeutics Q4 Net Income USD -23.577 Million